The Effects of COVID-19 on the Placenta During Pregnancy

Front Immunol. 2021 Sep 15:12:743022. doi: 10.3389/fimmu.2021.743022. eCollection 2021.

Abstract

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. The virus primarily affects the lungs where it induces respiratory distress syndrome ranging from mild to acute, however, there is a growing body of evidence supporting its negative effects on other system organs that also carry the ACE2 receptor, such as the placenta. The majority of newborns delivered from SARS-CoV-2 positive mothers test negative following delivery, suggesting that there are protective mechanisms within the placenta. There appears to be a higher incidence of pregnancy-related complications in SARS-CoV-2 positive mothers, such as miscarriage, restricted fetal growth, or still-birth. In this review, we discuss the pathobiology of COVID-19 maternal infection and the potential adverse effects associated with viral infection, and the possibility of transplacental transmission.

Keywords: COVID-19; SARS-CoV-2; placenta; pregnancy; transplacental infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Abortion, Spontaneous / virology
  • Angiotensin-Converting Enzyme 2 / metabolism
  • COVID-19 / pathology*
  • Female
  • Fetal Growth Retardation / virology
  • Humans
  • Maternal-Fetal Exchange / physiology
  • Placenta / pathology*
  • Placenta / virology*
  • Pregnancy
  • Pregnancy Complications, Infectious / virology*
  • SARS-CoV-2 / pathogenicity
  • Serine Endopeptidases / metabolism
  • Stillbirth

Substances

  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2
  • Serine Endopeptidases
  • TMPRSS2 protein, human